[Enhanced bioavailability of acetohexamide by beta-cyclodextrin complexation (author's transl)]. 1980

K Uekama, and N Matsuo, and F Hirayama, and H Ichibagase, and K Arimori, and K Tsubaki, and K Satake

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008297 Male Males
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002463 Cell Membrane Permeability A quality of cell membranes which permits the passage of solvents and solutes into and out of cells. Permeability, Cell Membrane
D003505 Cyclodextrins A homologous group of cyclic GLUCANS consisting of alpha-1,4 bound glucose units obtained by the action of cyclodextrin glucanotransferase on starch or similar substrates. The enzyme is produced by certain species of Bacillus. Cyclodextrins form inclusion complexes with a wide variety of substances. Cycloamylose,Cyclodextrin,Cyclodextrin Derivatives,Cyclomaltooligosaccharides,Derivatives, Cyclodextrin
D003912 Dextrins A group of low-molecular-weight carbohydrates produced by the hydrolysis of STARCH or GLYCOGEN. They are mixtures of polymers of D-glucose units linked by alpha-(1->4) or alpha-(1->6) glycosidic bonds. Dextrin
D000092 Acetohexamide A sulfonylurea hypoglycemic agent that is metabolized in the liver to 1-hydrohexamide. Dimelor,Dymelor,Gamadiabet
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013213 Starch Any of a group of polysaccharides of the general formula (C6-H10-O5)n, composed of a long-chain polymer of glucose in the form of amylose and amylopectin. It is the chief storage form of energy reserve (carbohydrates) in plants. Amylomaize Starch,Amylum,Cornstarch,Keoflo,Starch, Amylomaize

Related Publications

K Uekama, and N Matsuo, and F Hirayama, and H Ichibagase, and K Arimori, and K Tsubaki, and K Satake
April 1981, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
K Uekama, and N Matsuo, and F Hirayama, and H Ichibagase, and K Arimori, and K Tsubaki, and K Satake
December 2007, Bioscience, biotechnology, and biochemistry,
K Uekama, and N Matsuo, and F Hirayama, and H Ichibagase, and K Arimori, and K Tsubaki, and K Satake
September 1981, Journal of pharmacobio-dynamics,
K Uekama, and N Matsuo, and F Hirayama, and H Ichibagase, and K Arimori, and K Tsubaki, and K Satake
June 1998, Drug development and industrial pharmacy,
K Uekama, and N Matsuo, and F Hirayama, and H Ichibagase, and K Arimori, and K Tsubaki, and K Satake
December 1982, Journal of pharmacobio-dynamics,
K Uekama, and N Matsuo, and F Hirayama, and H Ichibagase, and K Arimori, and K Tsubaki, and K Satake
October 1993, Journal of pharmaceutical sciences,
K Uekama, and N Matsuo, and F Hirayama, and H Ichibagase, and K Arimori, and K Tsubaki, and K Satake
November 1988, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
K Uekama, and N Matsuo, and F Hirayama, and H Ichibagase, and K Arimori, and K Tsubaki, and K Satake
January 1995, Pharmacological research,
K Uekama, and N Matsuo, and F Hirayama, and H Ichibagase, and K Arimori, and K Tsubaki, and K Satake
January 2000, Pharmaceutical development and technology,
K Uekama, and N Matsuo, and F Hirayama, and H Ichibagase, and K Arimori, and K Tsubaki, and K Satake
July 2001, Drug development and industrial pharmacy,
Copied contents to your clipboard!